NL-OMON47096
Completed
Not Applicable
Molecular imaging of coronary plaque vulnerability using 18F-fluorocholine PET-MRI in patients with coronary artery disease - 18F-fluorocholine PET-MR imaging of coronary plaque vulnerability
Medisch Universitair Ziekenhuis Maastricht0 sites35 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Medisch Universitair Ziekenhuis Maastricht
- Enrollment
- 35
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Protocol optimization (stable AP patients included at MUMC\+: additional PET\-MRI);\* Diagnosed with stable angina pectoris and scheduled for a PCI procedure at the MUMC
- •\* Minimum age of 18 years
- •\* Mentally competent
- •\* Having provided informed written consent ;Patients included at Viecuri hospital: additional PET\-MRI and OCT;\* NSTEMI or STEMI patients who underwent urgent percutaneous coronary intervention (PCI) of the culprit vessel, who are diagnosed with multivessel coronary disease and are currently scheduled for a second PCI at the VieCuri hospital
- •\* Currently stable and scheduled for another PCI at the VieCuri hospital to stent another coronary vessel
- •\* Able to visit the MUMC by own transport / train for PET\-MR imaging before the new PCI procedure
- •\* Minimum age of 18 years
- •\* Mentally competent
- •\* Having provided informed written consent
- •Patients included at MUMC\+: additional PET\-MRI;\* Recently diagnosed with NSTEMI and scheduled for a PCI at the MUMC
Exclusion Criteria
- •\* Conservatively managed patients who are not scheduled for percutaneous coronary intervention (PCI)
- •\* Patients requiring PCI \< 24 hours after admission
- •\* Hemodynamic instability and cardiogenic shock (mean arterial pressure \< 60 mmHg)
- •\* Severe heart failure (Killip Class \* III)
- •\* Chest pain highly suggestive of non\-cardiac origin (as judged by the cardiac
- •physician/cardiologist)
- •\* Atrial fibrillation with ventricular rate \*100 beats per minute (bpm)
- •\* Tachycardia (\* 100/bpm)
- •\* Pregnancy
- •\* Breast feeding women
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Plaque at risk (ParisK): Molecular imaging of plaque vulnerability using 18F-choline PET-MRI in patients with carotid artery atherosclerosisarteriosclerosisatherosclerotic plaquecalcification in the vessel wall10003216NL-OMON47871Medisch Universitair Ziekenhuis Maastricht25
Active, not recruiting
Phase 1
Molecular imaging of plaque vulnerabilityPatients with carotid artery stenosis due to atherosclerosis, who are scheduled for carotid endarterectomy or are treated conservatively.MedDRA version: 21.1 Level: PT Classification code 10066537 Term: Atherosclerosis prophylaxis System Organ Class: 10042613 - Surgical and medical proceduresTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]EUCTR2013-000456-17-NLniversity Hospital Maastricht25
Completed
Not Applicable
18F-fluorocholine PET-MR Imaging of Coronary Plaque VulnerabilityMyocardial InfarctionMyocardial IschemiaAtherosclerosisCoronary Artery DiseaseCoronary StenosisHeart AttackMulti Vessel Coronary Artery DiseaseNCT03252990Maastricht University Medical Center15
Recruiting
Not Applicable
The evaluation of coronary plaque using imaging modalitiesJPRN-UMIN000054015Saitama Medical Center, Jichi Medical University20
Completed
Not Applicable
Imaging of Vulnerable Plaques in Coronary Artery Disease by Multidetector Computed TomographyAtherosclerosisNCT00482651University of Aarhus60